Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study

Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study

Cardiac dysfunction is an important prognostic predictor of cardiovascular mortality in patients on hemodialysis (HD). Erythropoietin (EPO) has been reported to improve cardiac function by binding to the EPO receptor (EPOR) on cardiomyocytes. This study investigated whether anti-EPOR antibodies were...

Full description

Bibliographic Details
Main Authors: Yasuhiro Mochida, Akinori Hara, Machiko Oka, Kyoko Maesato, Kunihiro Ishioka, Hidekazu Moriya, Megumi Oshima, Tadashi Toyama, Shinji Kitajima, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Yoshitaka Koshino, Takayasu Ohtake, Sumi Hidaka, Shuzo Kobayashi, Takashi Wada
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
erythropoietin (EPO)
erythropoietin receptor (EPOR)
anti-erythropoietin receptor antibodies
hemodialysis (HD)
left ventricular hypertrophy
cardiac function
Online Access:https://www.mdpi.com/2227-9059/10/9/2092

Internet

https://www.mdpi.com/2227-9059/10/9/2092

Similar Items